Literature DB >> 3116331

Localization of pipecolic acid metabolism in rat liver peroxisomes: probable explanation for hyperpipecolataemia in Zellweger syndrome.

J M Trijbels1, L A Monnens, G Melis, M van den Broekvan Essen, M Bruckwilder.   

Abstract

The metabolism of [14C]pipecolic acid was studied in peroxisomal fractions of rat liver obtained by density gradient centrifugation in Percoll. The production rate of [14CO2] was used to measure the metabolic activity of the fractions towards [14C]carboxypipecolic acid as a substrate. It was shown that this activity was located in the peroxisomal fractions by comparison with the peroxisomal marker enzyme urate oxidase (EC 1.7.3.3). The process was markedly elevated by the addition of FAD. The apparent Km for DL-pipecolic acid was found to be 1.2 mmol L-1. Addition of ATP (1 mmol L-1) did not influence the decarboxylation rate of pipecolic acid. These results might explain the defective metabolism of pipecolic acid in patients with Zellweger syndrome who are lacking peroxisomes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116331     DOI: 10.1007/bf01800037

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  14 in total

1.  Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism.

Authors:  D M Danks; P Tippett; C Adams; P Campbell
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.

Authors:  B T Poll-The; J M Saudubray; H Ogier; R B Schutgens; R J Wanders; G Schrakamp; H van den Bosch; J M Trijbels; A Poulos; H W Moser
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Conversion of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid into cholic acid by rat liver peroxisomes.

Authors:  J I Pedersen; J Gustafsson
Journal:  FEBS Lett       Date:  1980-12-01       Impact factor: 4.124

4.  Evidence that peroxisomal acyl-CoA synthetase is located at the cytoplasmic side of the peroxisomal membrane.

Authors:  G P Mannaerts; P Van Veldhoven; A Van Broekhoven; G Vandebroek; L J Debeer
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

5.  Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

Authors:  F R Brown; A J McAdams; J W Cummins; R Konkol; I Singh; A B Moser; H W Moser
Journal:  Johns Hopkins Med J       Date:  1982-12

6.  Pipecolic acid is oxidized by renal and hepatic peroxisomes. Implications for Zellweger's cerebro-hepato-renal syndrome (CHRS).

Authors:  K Zaar; S Angermüller; A Völkl; H D Fahimi
Journal:  Exp Cell Res       Date:  1986-05       Impact factor: 3.905

7.  Biochemical studies in the liver and muscle of patients with Zellweger syndrome.

Authors:  J M Trijbels; J A Berden; L A Monnens; J L Willems; A J Janssen; R B Schutgens; M van den Broek-Van Essen
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

8.  Serum very long chain fatty acid pattern in Zellweger syndrome.

Authors:  J A Bakkeren; L A Monnens; J M Trijbels; J M Maas
Journal:  Clin Chim Acta       Date:  1984-04-27       Impact factor: 3.786

9.  Induction of peroxisomal beta-oxidation in rat liver by high-fat diets.

Authors:  C E Neat; M S Thomassen; H Osmundsen
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

10.  Hyperpipecolic acidemia in neonatal adrenoleukodystrophy.

Authors:  R I Kelley; H W Moser
Journal:  Am J Med Genet       Date:  1984-12
View more
  2 in total

1.  Species variation in organellar location and activity of L-pipecolic acid oxidation in mammals.

Authors:  S J Mihalik; W J Rhead
Journal:  J Comp Physiol B       Date:  1991       Impact factor: 2.200

Review 2.  Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the Brain.

Authors:  André Hallen; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2016-08-12       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.